Theseus Pharmaceuticals News - THRX

Company Name	Stock Ticker Symbol	Market	Type
Theseus Pharmaceuticals Inc	THRX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	4.06	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			4.06	4.06

more quote information »

Recent News

Date	Time	Source	Heading
2/26/2024	09:00	EDGAR2	Form 15-12G - Securities registration termination [Section..
2/16/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2/14/2024	16:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	14:26	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
2/14/2024	14:22	EDGAR2	Form POS AM - Post-Effective amendments for registration..
2/14/2024	10:44	EDGAR2	Form 8-K - Current report
2/14/2024	10:35	EDGAR2	Form SC TO-T/A - Tender offer statement by Third Party:..
2/14/2024	08:30	PRNUS	Theseus Pharmaceuticals Announces Closing of Tender Offer
2/13/2024	12:36	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/07/2024	17:21	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
2/07/2024	17:15	EDGAR2	Form SC TO-T/A - Tender offer statement by Third Party:..
1/30/2024	08:52	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
1/30/2024	08:23	EDGAR2	Form SC TO-T/A - Tender offer statement by Third Party:..
1/30/2024	08:00	BW	Concentra Announces Calculation of Additional Price Per..
1/10/2024	09:47	EDGAR2	Form SC 14D9 - Solicitation, recommendation statements
1/10/2024	08:51	EDGAR2	Form SC TO-T - Tender offer statement by Third Party
12/22/2023	06:52	EDGAR2	Form SC14D9C - Written communication relating to third party..
12/22/2023	06:36	EDGAR2	Form 8-K - Current report
12/22/2023	06:30	PRNUS	Theseus Pharmaceuticals Enters into Agreement to Be Acquired..
12/04/2023	06:30	EDGAR2	Form 8-K - Current report
11/27/2023	06:37	EDGAR2	Form 8-K - Current report
11/27/2023	06:30	PRNUS	Theseus Pharmaceuticals Confirms Receipt of Unsolicited..
11/24/2023	16:23	EDGAR2	Form SC 13D/A - General statement of acquisition of..
11/17/2023	16:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/15/2023	07:00	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
11/13/2023	16:05	PRNUS	Theseus Pharmaceuticals Announces Process to Explore..
11/07/2023	16:05	PRNUS	Theseus Pharmaceuticals to Participate in the Stifel 2023..
11/07/2023	16:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/31/2023	16:13	EDGAR2	Form 8-K - Current report
8/10/2023	07:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	07:05	EDGAR2	Form 8-K - Current report
8/10/2023	07:00	PRNUS	Theseus Pharmaceuticals Announces Business Highlights and..
7/19/2023	14:41	EDGAR2	Form SC 13D/A - General statement of acquisition of..
7/14/2023	07:51	IHMARKETNEWS	Friday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..
7/13/2023	16:08	EDGAR2	Form 8-K - Current report
7/13/2023	16:05	PRNUS	Theseus Pharmaceuticals to Discontinue Enrollment in Phase..
5/31/2023	07:00	PRNUS	Theseus Pharmaceuticals to Participate in the Jefferies..
5/25/2023	17:01	PRNUS	Theseus Pharmaceuticals Reports Initial Dose Escalation Data..
5/11/2023	07:00	PRNUS	Theseus Pharmaceuticals Announces Business Highlights and..
4/26/2023	10:05	PRNUS	Theseus Pharmaceuticals Initial Dose Escalation Results from..